CDK4/6-inhibitor or Chemotherapy, in Combination With ENDOcrine Therapy, for Advanced Breast Cancer / KENDO
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive Breast Cancer|Metastatic Breast Cancer|Hormone Receptor Negative Breast Cancer
Interventions: DRUG: concomitant cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor plus endocrine therapy|DRUG: chemotherapy plus endocrine therapy (administered either concomitantly or sequentially)
Sponsor: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Collaborators: Agenzia Italiana del Farmaco